Decoding the Future of K-Bio Value
Navigating the Quantum Leap of K-Bio
-
K-Bio Industry Overview: 2025 Performance and 2026 Outlook In 2025, the K-Bio industry demonstrated solid growth, driven by expanding global demand for biopharmaceuticals and the strengthening competitiveness of Korean biotech companies. Exports of biopharmaceutical products increased steadily, supported by large-scale biologics manufacturing, growing biosimilar penetration, and continued progress in innovative…
-
Korea’s Serial Deal-Maker: From Lazertinib Royalties to a Global Licensing Platform Ticker KOSDAQ: 039200 Current Price (June 2026) ~42,200 KRW Market Cap ~1.6 trillion KRW (~USD 1.2B) Sector Biopharma / Drug Discovery Report Date Jun 07, 2026 1. Executive Summary Oscotec Inc. (KOSDAQ: 039200) is a South Korean clinical-stage biotechnology…
● Latest Articles
-
Hanmi Pharm
1. LAPSCOVERY™: The Verified Bio-Platform Hanmi’s core technical advantage is the LAPSCOVERY™ (Long-Acting Protein/Peptide Discovery) technology. LAPSCOVERYTM Long Acting Protein / Peptide Discovery Platform Technology Overview Biologics have…
-
Samsung Bioepis
The Shift from “First Mover” to “Smart Follower” and Innovation In 2026, Samsung Bioepis is executing a dual-track strategy: stabilizing its massive biosimilar engine while…
-
Celltrion
Celltrion’s strategy is built on three technological driving forces: SC Formulation (Drug Delivery), Next-Gen ADC (Precision Oncology), and Multispecific Antibodies (Immune Modulation). 1. High-Concentration SC…
-
LigaChem Bio
* ADC (Antibody-Drug Conjugate) background The “Smart Bomb” or “Guided Missile” for cancer. For those new to the world of biotechnology, ADC (Antibody-Drug Conjugate) can…
● About Me
“PhD Scientist & 10-Year K-Bio Investor: Decoding the Life Science of Value.”
I am a Life Sciences PhD with industrial R&D experience across mAbs, BsAbs, ADCs, Vaccines, Cell/Gene Therapy and Medical Devices. By merging my technical expertise with over a decade of active investment in the K-Bio market, I translate complex innovation into clear, data-driven insights to help you find the real value behind the jargon.
K-Bio Value Report 